MedCap AB (Sweden) Performance
| MCAP Stock | SEK 493.00 2.50 0.51% |
The company secures a Beta (Market Risk) of 0.0713, which conveys not very significant fluctuations relative to the market. As returns on the market increase, MedCap AB's returns are expected to increase less than the market. However, during the bear market, the loss of holding MedCap AB is expected to be smaller as well. At this point, MedCap AB has a negative expected return of -0.16%. Please make sure to verify MedCap AB's jensen alpha, treynor ratio, and the relationship between the standard deviation and total risk alpha , to decide if MedCap AB performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days MedCap AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors. ...more
| Begin Period Cash Flow | 146.5 M | |
| Total Cashflows From Investing Activities | -64.8 M |
MedCap |
MedCap AB Relative Risk vs. Return Landscape
If you would invest 54,600 in MedCap AB on November 7, 2025 and sell it today you would lose (5,300) from holding MedCap AB or give up 9.71% of portfolio value over 90 days. MedCap AB is generating negative expected returns and assumes 1.6185% volatility on return distribution over the 90 days horizon. Simply put, 14% of stocks are less volatile than MedCap, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
MedCap AB Target Price Odds to finish over Current Price
The tendency of MedCap Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 493.00 | 90 days | 493.00 | over 95.5 |
Based on a normal probability distribution, the odds of MedCap AB to move above the current price in 90 days from now is over 95.5 (This MedCap AB probability density function shows the probability of MedCap Stock to fall within a particular range of prices over 90 days) .
MedCap AB Price Density |
| Price |
Predictive Modules for MedCap AB
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as MedCap AB. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.MedCap AB Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. MedCap AB is not an exception. The market had few large corrections towards the MedCap AB's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold MedCap AB, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of MedCap AB within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.35 | |
β | Beta against Dow Jones | 0.07 | |
σ | Overall volatility | 27.72 | |
Ir | Information ratio | -0.24 |
MedCap AB Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of MedCap AB for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for MedCap AB can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| MedCap AB generated a negative expected return over the last 90 days | |
| MedCap AB has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| About 30.0% of the company outstanding shares are owned by corporate insiders |
MedCap AB Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of MedCap Stock often depends not only on the future outlook of the current and potential MedCap AB's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. MedCap AB's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 107.5 M | |
| Cash And Short Term Investments | 139.7 M |
MedCap AB Fundamentals Growth
MedCap Stock prices reflect investors' perceptions of the future prospects and financial health of MedCap AB, and MedCap AB fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on MedCap Stock performance.
| Return On Equity | 0.15 | |||
| Return On Asset | 0.0822 | |||
| Profit Margin | 0.10 % | |||
| Operating Margin | 0.15 % | |||
| Current Valuation | 3.15 B | |||
| Shares Outstanding | 14.81 M | |||
| Price To Earning | 197.02 X | |||
| Price To Book | 3.83 X | |||
| Price To Sales | 2.95 X | |||
| Revenue | 916.3 M | |||
| EBITDA | 200.3 M | |||
| Cash And Equivalents | 139.7 M | |||
| Cash Per Share | 1.17 X | |||
| Total Debt | 165.4 M | |||
| Debt To Equity | 102.00 % | |||
| Book Value Per Share | 57.83 X | |||
| Cash Flow From Operations | 116.3 M | |||
| Earnings Per Share | 7.98 X | |||
| Total Asset | 1.17 B | |||
| Current Asset | 392 M | |||
| Current Liabilities | 251 M | |||
About MedCap AB Performance
Assessing MedCap AB's fundamental ratios provides investors with valuable insights into MedCap AB's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the MedCap AB is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
MedCap AB is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, growth capital, middle market, mature, turnarounds, buyout. MedCap AB was founded in 2001 and is based in Stockholm, Sweden. MedCap AB operates under Medical Equipment classification in Sweden and is traded on Stockholm Stock Exchange.Things to note about MedCap AB performance evaluation
Checking the ongoing alerts about MedCap AB for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for MedCap AB help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| MedCap AB generated a negative expected return over the last 90 days | |
| MedCap AB has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| About 30.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing MedCap AB's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether MedCap AB's stock is overvalued or undervalued compared to its peers.
- Examining MedCap AB's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating MedCap AB's management team can have a significant impact on its success or failure. Reviewing the track record and experience of MedCap AB's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of MedCap AB's stock. These opinions can provide insight into MedCap AB's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for MedCap Stock Analysis
When running MedCap AB's price analysis, check to measure MedCap AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MedCap AB is operating at the current time. Most of MedCap AB's value examination focuses on studying past and present price action to predict the probability of MedCap AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MedCap AB's price. Additionally, you may evaluate how the addition of MedCap AB to your portfolios can decrease your overall portfolio volatility.